Our previous studies demonstrated increased circulating MMP-2 and TIMP-2 levels in patients with CKD, which was associated with hypercoagulability, oxidative stress, inflammation, carotid atherosclerosis, and cardiovascular risk [20,21,22,23]. This evidence concerns the gene TIMP2 and chronic kidney disease.